Millendo Therapeutics Q3 EPS $(0.87) May Not Compare $(10.61) YoY

Millendo Therapeutics (NASDAQ:MLND) reported quarterly losses of $(0.87) per share. This is a 91.8 percent increase over losses of $(10.61) per share from the same period last year.

Benzinga · 11/13/2019 13:31

Millendo Therapeutics (NASDAQ:MLND) reported quarterly losses of $(0.87) per share. This is a 91.8 percent increase over losses of $(10.61) per share from the same period last year.